NewAmsterdam Pharma Co NV (NAMS)
16.26
+0.44
(+2.75%)
USD |
NASDAQ |
Sep 27, 16:00
16.26
0.00 (0.00%)
After-Hours: 20:00
NewAmsterdam Pharma Cash and Short Term Investments (Quarterly): 430.71M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 430.71M |
| March 31, 2024 | 481.15M |
| June 30, 2023 | 416.76M |
| December 31, 2022 | 467.73M |
| Date | Value |
|---|---|
| June 30, 2022 | 93.47M |
| June 30, 2022 | 93.47M |
| December 31, 2021 | 60.11M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
60.11M
Minimum
Dec 2021
481.15M
Maximum
Mar 2024
291.91M
Average
416.76M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Koninklijke Philips NV | -- |
| uniQure NV | 524.43M |
| ProQR Therapeutics NV | 103.07M |
| Merus NV | 787.42M |
| argenx SE | 3.102B |